Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Caladrius, Celltrion, Chromadex, CSL Behring, Eli Lilly, Emergent Biosolutions, Gilead Sciences, Glaxosmithkline, Grifols, Napajen, Noxopharm, Redhill Biopharma, Rigel, Seagen, Takeda, University of Oxford, Vir, Zai Lab.